Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Adcock Ingram Holdings Ltd - Midrand-based pharmaceutical manufacturer - Expects full-year earnings per share to grow at least 20% from 396.3 rand cents the year before. Expects an improvement in headline earnings per share at the same from the 404.7 cents. Attributes this to a better trading environment compared to last year which was negatively impacted by the Covid-19 pandemic. Adcock Ingram's financial year ended June 30.
Current stock price: R 48.27, up 2.7% on Friday
12-month change: up 12%
Copyright 2022 Alliance News Limited. All Rights Reserved.